High Prevalence of KatG Ser315Thr Substitution among Isoniazid-Resistant <i>Mycobacterium tuberculosis</i> Clinical Isolates from Northwestern Russia, 1996 to 2001
-
- Igor Mokrousov
- Laboratory of Molecular Microbiology, St. Petersburg Pasteur Institute
-
- Olga Narvskaya
- Laboratory of Molecular Microbiology, St. Petersburg Pasteur Institute
-
- Tatiana Otten
- Microbiology Laboratory, The Research Institute of Phthisiopulmonology
-
- Elena Limeschenko
- Laboratory of Molecular Microbiology, St. Petersburg Pasteur Institute
-
- Lidia Steklova
- City Anti-Tuberculosis Dispensary, St. Petersburg, Russia
-
- Boris Vyshnevskiy
- Microbiology Laboratory, The Research Institute of Phthisiopulmonology
抄録
<jats:title>ABSTRACT</jats:title> <jats:p> A total of 204 isoniazid (INH)-resistant strains of <jats:italic>Mycobacterium tuberculosis</jats:italic> isolated from different patients in the northwestern region of Russia from 1996 to 2001 were screened by a PCR-restriction fragment length polymorphism (RFLP) assay. This assay uses <jats:italic>Hap</jats:italic> II cleavage of an amplified fragment of the <jats:italic>katG</jats:italic> gene to detect the transversion 315AGC→ACC (Ser→Thr), which is associated with INH resistance. This analysis revealed a 93.6% prevalence of the <jats:italic>katG</jats:italic> S315T mutation in strains from patients with both newly and previously diagnosed cases of tuberculosis (TB). This mutation was not found in any of 57 INH-susceptible isolates included in the study. The specificity of the assay was 100%; all isolates that contained the S315T mutation were classified as resistant by a culture-based susceptibility testing method. The Beijing genotype, defined by IS <jats:italic>6110</jats:italic> -RFLP analysis and the spacer oligonucleotide typing (spoligotyping) method, was found in 60.3% of the INH-resistant strains studied. The <jats:italic>katG</jats:italic> S315T shift was more prevalent among Beijing genotype strains than among non-Beijing genotype strains: 97.8 versus 84.6%, respectively, for all isolates, including those from patients with new and previously diagnosed cases, isolated from 1999 to 2001 and 100.0 versus 86.5%, respectively, for isolates from patients with new cases isolated from 1996 to 2001. The design of this PCR-RFLP assay allows the rapid and unambiguous identification of the <jats:italic>katG</jats:italic> 315ACC mutant allele. The simplicity of the assay permits its implementation into routine practice in clinical microbiology laboratories in regions with a high incidence of TB where this mutation is predominant, including northwestern Russia. </jats:p>
収録刊行物
-
- Antimicrobial Agents and Chemotherapy
-
Antimicrobial Agents and Chemotherapy 46 (5), 1417-1424, 2002-05
American Society for Microbiology
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1364233271207952128
-
- NII論文ID
- 30020630583
-
- ISSN
- 10986596
- 00664804
-
- データソース種別
-
- Crossref
- CiNii Articles